Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP.LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Lamivudine and zidovudine tablets, a combination of two nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of HIV-1 infection.
- generic_name
- lamivudine and zidovudine
- product_names
- Lamivudine and Zidovudine
- ndc
- 76519-1005, 0093-5385, 76519-1005-6
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en